Stem Cell

Stem Cell

cryptocurrency, Health
Token sale is active until 17 January
Goal: 3,000,000 USD
Website Whitepaper
Stemcell

Stem Cell Innovations (SCI) is a network of highly motivated researchers, expert medical professionals, dedicated investors, and innovative engineers working together to create a unique platform that brings together two of the most life-changing innovations of the 21st century: stem cell technology and blockchain technology.

Since its initial founding in early 2013 under the name Camden RAD, LLC, SCI has played a crucial role in stem cell research and development around the world, and we has conducted our own domestic and international case studies to further the research in this exciting field. SCI’s activities in the field of stem cell science have directly contributed to advancements in the field, as well as to new stem cell discoveries around the world.

Stem cells are a unique type of multicell found in the body of human beings. It is an undifferentiated collection of cells that are capable of providing countless applications in the development of new cells for use in the treatment of diseases and conditions, recovery and restoration of body parts, and with our research and development, many more applications to come.

To date, SCI’s areas of study have included orthopedic, neurological, and pulmonary conditions, as well as oncological stem cell applications. Although research conducted by SCI has made strides in these areas of medicine, there remains
an immediate need for further research and development across a vast nexus of medical conditions that impact millions of people around the world. As a leader in stem cell research, SCI plans to continue to organize and participate in many more case studies to aggregate data that can be used to advance this innovative field.

Based on our research, we’ve been able to identify countless applications for stem cell therapies including treatments
for conditions such as bone marrow transplants, strokes, traumatic brain injuries, learning disorders, Alzheimer’s disease, missing teeth, wound healing, spinal cord injury, baldness, blindness, deafness, diabetes, Crohn’s disease, and multiple forms of cancer, as well as numerous other conditions. While advancements have been made in stem cell research previously, the introduction of blockchain technology means that more people can gain access to these potentially life-changing treatments — effectively changing the face of the medical community forever.

SCI, along with its affiliates, continues to closely monitors the evolution of stem cell therapy in different medical subspecialties around the world. SCI has created an online community that shares important information from stem cell professionals’ research and contributions across multiple social platforms so there is congruity amongst key players and those that are most interested in stem cell research and the impact it can make on people’s lives. SCI’s network fosters a community where sharing and teaching is encouraged to grow the stem cell industry. SCI’s online community offers access to videos, blogs, and articles about stem cell research that educate, inform, engage, and aim to increase awareness amongst professionals, patients and investors in the proliferation of the stem cell field.

Having recognized the potential industry-changing link between stem cell research with the secure nature of blockchain technology, SCI moves to bridge the gap between accessing and understanding of stem cell research and development around the world while creating a collaborative and effective network of key players in the industry.

Moe Galal
Chief Executive Officer / Founder
Ben Barel
Chief Operations Officer / Co-Founder
Ali Alrashidi
Chief Technology Officer / Co-Founder
Matt Galal
Chief of Staff / Co-Founder
Kobi Barel
Operations Engineer / Co-Founder
John Glavinovich, M.D.
Medical Director
Philip Glukhovsky, D.C.
Health Informatics Manager
Roger Williams
VP of Marketing
Liz Curlett
VP, PR & Corporate Communications
Candice Kouchache
Business Development
Ahmed Elsantawi
VP of International Human Resources
David Marmon
Web Designer
Heather Deveaux
Copywriter
Everlecia Taylor
Creative Writer
Michelle Chavon
Marketing
Token Sale: 21 November — 17 January
Ticker
Token type
ICO Token Price
Available for Token Sale
Whitelist
Know Your Customer
Сant participate
Min/Max Personal Cap
Accepts
3.25/5
Hype rate
Risk rate
ROI rate
Site Score

Add a comment